ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1121

$1.28M Total Retail Price of All Prescriptions

Rank: 32 out of 1121

634 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,741 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,314 870 S3 1 3
LEVOTHYROXINE SODIUM 668 538 2 2
FUROSEMIDE 611 442 3 7
SIMVASTATIN 556 433 4 1
AMLODIPINE BESYLATE 546 435 5 5
PANTOPRAZOLE SODIUM 518 399 6 29
LISINOPRIL 480 290 7 4
WARFARIN SODIUM 425 384 8 11
SERTRALINE HCL 418 346 9 21
DONEPEZIL HCL 390 385 10 35
NAMENDA 387 387 11 53
OMEPRAZOLE 384 262 12 6
METOPROLOL TARTRATE 381 330 13 9
CITALOPRAM HBR 319 279 14 18
OXYCODONE HCL 304 26 S2 15 68
GABAPENTIN 301 145 16 13
FENTANYL 289 222 S2 17 100
POTASSIUM CHLORIDE 286 213 18 12
PRAVASTATIN SODIUM 267 235 19 14
RISPERIDONE 253 232 20 82
CARISOPRODOL 244 28 R 21 72
MORPHINE SULFATE ER 242 39 S2 22 87
ATORVASTATIN CALCIUM 229 203 23 15
CYMBALTA 201 134 24 50
ATENOLOL 199 132 25 16
DIGOXIN 198 183 26 59
CLOPIDOGREL 197 179 27 27
NEXIUM 197 110 27 24
CARVEDILOL 194 175 29 20
ZOLPIDEM TARTRATE 191 113 30 19
MELOXICAM 187 147 31 22
TRAZODONE HCL 179 142 32 40
CEFDINIR 178 132 33 183
SPIRIVA 173 102 34 49
LYRICA 172 89 35 76
LOVASTATIN 169 107 36 26
DIOVAN 157 146 37 45
PREDNISONE 153 98 38 43
LEVOFLOXACIN 151 104 39 79
TAMSULOSIN HCL 151 128 39 32
METFORMIN HCL 151 89 39 8
PLAVIX 147 133 42 42
METOPROLOL SUCCINATE 144 140 43 23
HYDROCHLOROTHIAZIDE 139 125 44 10
LOSARTAN POTASSIUM 139 104 44 17
OXYCODONE HCL-ACETAMINOPHEN 135 48 S2 46 86
QUETIAPINE FUMARATE 133 117 47 75
MIRTAZAPINE 126 111 48 56
CLONIDINE HCL 117 84 49 39
FAMOTIDINE 117 96 49 63
PROMETHAZINE HCL 114 61 R 51 67
TRIAMTERENE-HCTZ 112 90 52 38
RANITIDINE HCL 111 85 53 33
ADVAIR DISKUS 110 67 54 64
CARBIDOPA-LEVODOPA 108 84 55 118
SEROQUEL 102 85 56 134
GEMFIBROZIL 97 51 57 88
TRAMADOL HCL 97 78 57 25
DIVALPROEX SODIUM 97 90 57 98
PHENYTOIN SODIUM EXTENDED 96 53 60 135
ESTRADIOL 95 56 R 61 95
ISOSORBIDE MONONITRATE ER 95 83 61 62
ALLOPURINOL 93 92 63 30
PAROXETINE HCL 93 62 63 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 76 63 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 66 66 31
VESICARE 91 86 67 186
HYDRALAZINE HCL 90 80 68 66
ENDOCET 90 23 S2 68 107
FLUOXETINE HCL 90 59 68 60
SPIRONOLACTONE 86 48 71 54
OXYCODONE-ACETAMINOPHEN 85 76 S2 72 122
METOCLOPRAMIDE HCL 84 33 73 120
ESCITALOPRAM OXALATE 84 76 73 94
PROAIR HFA 82 27 75 48
LANTUS 82 78 75 52
FLUTICASONE PROPIONATE 82 54 75 36
ENALAPRIL MALEATE 81 62 78 73
LACTULOSE 81 50 78 132
CELEBREX 81 63 78 104
EXELON 80 80 81 119
BACLOFEN 79 34 82 131
AMLODIPINE BESYLATE-BENAZEPRIL 79 48 82 65
CRESTOR 78 51 84 28
KLOR-CON M20 77 51 85 85
LEVETIRACETAM 75 26 86 125
FLUCONAZOLE 75 67 86 156
PRAMIPEXOLE DIHYDROCHLORIDE 74 73 88 158
OXYCONTIN 74 14 S2 88 165
NITROFURANTOIN 69 56 90 231
DEXILANT 68 21 91 136
VENTOLIN HFA 68 11 91 92
POLYETHYLENE GLYCOL 3350 65 54 93 70
BENAZEPRIL HCL 65 61 93 41
AMITRIPTYLINE HCL 64 22 R 95 61
LOSARTAN-HYDROCHLOROTHIAZIDE 63 41 96 46
CYCLOBENZAPRINE HCL 62 17 R 97 83
SINGULAIR 59 35 98 78
ZETIA 57 57 99 80
HUMULIN R 57 56 99 227
PREMARIN 56 41 R 101 96
AMOX TR-POTASSIUM CLAVULANATE 56 34 101 101
MECLIZINE HCL 56 38 101 115
QUINAPRIL HCL 55 49 104 127
AZITHROMYCIN 54 32 105 44
FINASTERIDE 54 32 105 117
COMBIVENT 53 38 107 129
NIASPAN 53 41 107 166
DOXAZOSIN MESYLATE 52 40 109 93
MEGESTROL ACETATE 52 47 R 109 185
NOVOLIN R 52 42 109 174
GLIPIZIDE 51 48 112 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.